SOURCE: Elsevier

Elsevier

February 07, 2012 08:00 ET

Elsevier and Informex Global Launch Elsevier Tech Talks at Informex 2012

New Technical Conference Highlights Cutting-Edge Research in the Chemicals Industry

NEW YORK, NY--(Marketwire - Feb 7, 2012) - Elsevier (NYSE: ENL), the world's leading provider of scientific, technical and medical information products and services, and Informex Global, the leading meeting place for buyers and sellers of high-value chemistry, today announced the introduction of a new feature to the Informex 2012 line-up. Elsevier Tech Talks -- a speaker series serving as an expansion to the existing educational offerings from Informex. Elsevier Tech Talks offers two no cost, full-day programs at Informex 2012, New Orleans February 14-17, 2012, where distinguished researchers will give 30-40 minute presentations on recent research that is applicable to the specialty and fine chemical community. Speakers include executives from top-level companies including DSM, Sherwin-Williams, Kodak Specialty Chemicals, WeylChem and SAFC. The full schedule and location for the Elsevier Tech Talks can be found at: www.informex.com/elsevier-tech-talks.

The Elsevier Tech Talks presentations are unique due to an exclusive technology and research focus. Invited speakers are given open reign when choosing the process or technology they will highlight, as long as the information is applicable to their colleagues at Informex. Another differentiating factor of the Tech Talks presentation is the removal of any promotional content as the driving force of the presentations is to encourage information and technology transfer amongst colleagues in the chemical and pharma industries. Throughout the two days of presentations, visitors will be able to gain information on a variety of topics including sustainability, synthesis, fluorination, compound manufacture and more.

"We could not think of a better venue to premiere Elsevier Tech Talks than Informex, and we are excited to see how it is received," said Shandon Quinn, Director of Market Development for Elsevier's chemical business. "We wanted to offer a different approach to the classic conference session. As such, all presentations in the series have a technology and chemistry focus that delivers a unique R&D dimension to the show."

Caitlin Devlin, Marketing Manager at Informex, agreed that, "The Tech Talks offer guests at Informex a unique format to learn about new technologies and research processes that they may not previously have had access to. The series is comprehensive and supports the idea that success in this market comes from continually learning, growing and partnering for the future. We are pleased to introduce the series as part of the Informex 2012 line-up."

In addition to hosting the Tech Talks at Informex 2012, Elsevier will also be onsite as an exhibitor at booth #846 where they will offer insight into information tools for the fine and specialty chemical and pharma industries, highlighting two key products, Reaxys® and SciVerse ScienceDirect. Reaxys enables the discovery of new compounds and optimal reaction pathways using deeply excerpted chemistry information from leading chemistry journals and relevant patent classes, while SciVerse ScienceDirect offers chemists and chemical engineers full-text, peer-reviewed book and journal content.

To learn more about the Elsevier Tech Talks presentations and scheduling details, please,visit www.informex.com/elsevier-tech-talks and follow @ElsevierChem on Twitter during the show.

To learn more about Elsevier's information tools for the fine and specialty chemical industries, visit www.ElsevierChem.com and ElsevierPharma.com.

To learn more about Informex, please visit: http://www.informex.com.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet (www.thelancet.com) and Cell (www.cell.com), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect (www.sciencedirect.com), Scopus (www.scopus.com), Reaxys (www.reaxys.com), MD Consult (www.mdconsult.com) and Nursing Consult (www.nursingconsult.com), which enhance the productivity of science and health professionals, and the SciVal suite (www.scival.com) and MEDai's Pinpoint Review (www.medai.com), which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier (www.elsevier.com) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (www.reedelsevier.com), a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Reaxys® and the Reaxys® trademark are owned and protected by Elsevier Properties SA. All rights reserved.

About Informex
Organized by UBM Live, Informex is the leading meeting place for buyers and sellers of high-value chemistry for a broad range of applications. As the premier, must-attend, event for the chemical industry for the past 27 years, Informex is a marketplace for networking and doing business in the fine, custom and specialty chemical manufacturing industry. The show traces its origin to a group of members from the Society of Chemical Manufacturers and Associates (SOCMA) who were looking for an annual place to meet and do business. Each year the event brings together an international mix of more than 4,000 fine and specialty chemicals professionals and 500 exhibitors for the all encompassing, 4 day event.